Media

News

Are you a media representative looking for content on Bayer? This section provides access to media releases as well as feeds from our social media channels.

April 11, 2017

Bayer launches Grants4AppsToronto

Three digital health startups, 88 days and a once in a lifetime opportunity to be mentored by a global leader in life sciences Read more
March 20, 2017

Bayer's Canadian contraception family is growing with the launch of Kyleena®.

Kyleena is an effective, low-dose, five-year birth control option that women don't have to worry about taking every day. Read more
December 12, 2016

Bayer and Versant Ventures Join Forces to Launch Stem Cell Therapy Company BlueRock Therapeutics with USD 225 Million Series A Financing

BlueRock Therapeutics is focused on breakthrough treatments based on latest stem cell technology in combination with superior cell differentiation protocols. BlueRock Therapeutics’ vision is to cure diseases with significant cell loss and diminished self-repair potential with an initial focus on cardiovascular, neurological and other conditions. Read more
November 07, 2016

Bayer is proud to be recognized as a top 100 employer for 10 years running

Bayer Inc. is excited to be recognized for the 10th time in a row as a Top 100 Employer in Canada. Bayer’s management team prides itself as having a stellar employee retention rate of some 96 per cent and employee satisfaction levels of 92 per cent and above. Read more
September 14, 2016

Bayer and Monsanto to Create a Global Leader in Agriculture

Realizes a shared vision of integrated agricultural offerings, delivering enhanced solutions for growers and creates a leading innovation engine for the next generation of farming. USD 128 per share in all-cash transaction, represents 44 percent premium to Monsanto shareholders and an aggregate value of USD 66 billion. Significant value creation with expected annual synergies of approximately USD 1.5 billion after year three; plus additional synergies from integrated solutions in future years. Bayer shareholders expected to benefit from accretion to core EPS in the first full year after closing and double-digit percentage accretion in the third full year. Committed to retaining strong presence in the U.S. with the combined business’ global Seeds & Traits and North American commercial headquarters in St. Louis. Read more
September 01, 2016

Bayer Inc. Launches the First DNA Immunostimulant in Canada for Bovine Respiratory Disease (BRD)

Zelnate® jumpstarts animal's innate immunity, offering an innovative non-antibiotic approach to help mitigate BRD Read more
August 26, 2016

ALEVE® AND JAYS CARE FOUNDATION STEP UP TO HELP STRIKE-OUT ARTHRITIS

Introducing Help Strike-Out Arthritis from ALEVE®. For every home game strike-out by a Blue JaysTM reliever, ALEVE will donate $1,200 to The Arthritis Society of Canada Read more
August 17, 2016

Bayer and the Canadian Vascular Network (CVN) Announce the 2016 Research Fellowship Awards

Two Recipients Selected, Dr. Jason Christopher Weatherald and Dr. Don Thiwanka Dilshan Wijeratne Read more
June 10, 2016

Wheat Breeding Station leverages Bayer's global program to find local solutions for Canadian wheat growers

New varieties and traits will be tailored to the unique challenges Canadian growers face, enhancing their ability to remain competitive in global markets Read more
May 24, 2016

Bayer Comments on Monsanto's Statement Regarding P...

Bayer announced today that it looks forward to eng... Read more